Background and aims-Lactulose fermentation by the intestinal microflora acidifies the gut contents, resulting in an increased resistance to colonisation by acid sensitive pathogens. The extent of fermentation should be controlled to prevent acid induced epithelial cell damage. Considering the buffering capacity of calcium phosphate and its intestinal cytoprotective effects, whether supplemental calcium phosphate adds to the increased resistance to intestinal infections by lactulose fermentation was studied. Methods-In a strictly controlled experiment, rats were fed a purified low calcium control diet, a low calcium/lactulose diet, or a high calciuni/lactulose diet, and subsequently infected orally with Salmonella enteritidis. Results-Lactulose fermentation lowered the pH and increased the lactic acid concentration of the intestinal contents, which significantly reduced excretion of this pathogen in faeces; thus it improved the resistance to colonisation. This agreed with the high sensitivity of S enteritidis to lactic acid (main metabolite of lactulose fermentation) in vitro. Calcium phosphate decreased translocation ofS enteritidis to the systemic circulation, an effect independent of lactulose. The unfavourable increased cytotoxicity of faecal water caused by lactulose fermentation was more than counteracted by supplemental calcium phosphate. Moreover, calcium phosphate stimulated lactulose fermentation, as judged by the reduced lactulose excretion in faeces and increased lactic acid, ammonia, and faecal nitrogen excretion. Conclusion-Extra calcium phosphate added to a lactulose diet improves the resistance to colonisation and translocation of S enteritidis. This is probably mediated by a calcium induced stimulation of lactulose fermentation by the intestinal microflora and reversion of the lactulose mediated increased luminal cytotoxicity, which reduces damage inflicted on the intestinal mucosa. (Gut 1997; 40: 497-504) 
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The disaccharide lactulose (4-0-3-D-galactopyranosyl-ot-D-fructofuranose) is a drug mainly used as a laxative and as treatment for portosystemic encephalopathy.1 After oral administration, lactulose reaches the lower gut unaltered because it is neither absorbed nor hydrolysed by host digestive enzymes. Although its action is not fully understood, it is supposed to depend on extensive fermentation by the intestinal microflora, resulting in enhanced bacterial growth, acidification of the gut contents because of the production of lactic acid and short chain fatty acids, trapping of ammonia, and stimulation of ammonia incorporation into bacterial protein. 2 Many Gram negative bacteria such as bacteroides, Escherichia coli, salmonella, and proteus seem to be incapable of degrading lactulose, by contrast with many Gram positive intestinal bacteria, such as lactobacilli and streptococci. Lactulose therapy has also been used successfully in the management of food borne intestinal infections and inflammatory bowel diseases.'4 Although they are probably one of the prerequisites for the above mentioned beneficial effects of lactulose, the acidic metabolites generated during strong fermentation have to be at least partially neutralised, to prevent damage to the intestinal mucosa. High concentrations of short chain fatty acids (for intance, acetic acid) may induce injury to the colon which is characterised by degeneration and extrusion of enterocytes, increased permeability, and epithelial cell proliferation.7-9 Therefore, the extent of intestinal fermentation should certainly be controlled. Faeces were quantitatively collected three days before salmonella infection and on days 2, 3, and 4 after infection. Faeces were freeze dried for dry weight determination. For determination of unfermented lactulose, 13 volumes of distilled water were added per mg freeze dried faeces. After homogenisation, samples were heated for five minutes at 95°C to denature glycosidases, followed by centrifugation (five minutes at 10000 g; Eppendorf 5415). Supernatants were cleared from hydrophobic substances on octadecyl columns (100 mg; Varian, Harbor City, USA). Water eluates were analysed for lactulose by high performance liquid chromatography (HPLC).20 Recoveries of lactulose added to faeces varied between 96% and 1 13%. For lactic acid determination, dry faeces were acidified with 1 0 M perchloric acid (1:40 w/v), mixed, and subsequently centrifuged (two minutes at 10000 g, Eppendorf 5415). The supematant was neutralised to pH 7 by adding 2-0 M potassium bicarbonate (2:1 v/v), followed by centrifugation (two minutes at 10000 g, Eppendorf 5415). D-and L-lactic acid in the supematant liquids were separately determined with a colorimetric enzymatic kit (No 11 12821, Boehringer Mannheim, Germany). Recoveries of lactic acid added to faeces were >90%. For ammonia determination, faeces were acidified with 5% perchloric acid (1:20 w/v), incubated for 15 minutes at 37°C, and centrifuged (two minutes at 14000 g, Eppendorf 5415). The aspirated supematant was neutralised to pH 7 by adding 3-0 M KOH in 250 mM 3-N-morpholinopropanesulphonic acid (10:3 v/v). After mixing, samples were centrifuged (two minutes at 14000 g, Eppendorf 5415). Ammonia in the supematants was determined using a colorimetric kit originally designed to measure urea ( 30 minutes at 3000 g). After drying of the membrane inserts by air, the mucin retentate was resolubilised in the original volume of phosphate buffered saline. Mucins were measured using a specific fluorimetric assay. 22 Standard solutions of N-acetylgalactosamine (Sigma) were used to calculate the amount of oligosaccharide side chains liberated from mucins. Faecal mucins are therefore expressed as ,umol oligosaccharide equivalents. Using this procedure, recoveries of porcine stomach mucin (Sigma) added to freeze dried faeces always exceeded 90%. After destruction (15 minutes at 180°C) with a perchloric acid (70%)/hydrogen peroxide (30%) mixture (3:1 v/v) of freeze dried faeces, calcium, total phosphate, and iron were measured as described for the diets. Inorganic phosphate was extracted from freeze dried faeces with 5% (w/v) trichloroacetic acid and measured as described above. The amount of organic phosphate in faeces was calculated by subtracting the inorganic phosphate concentration from the total phosphate concentration. In the trichloroacetic acid extracts sodium and potassium were analysed by atomic emission spectrophotometry (Model 1100, Perkin Elmer). Total bile acids were extracted from freeze dried faeces with a t-butanol/water mixture (1: 1 v/v) as described previously.23 Extracts were assayed for bile acids using a fluorimetric, enzymatic assay.24 Recovery of deoxycholic acid (Sigma) added to faeces always exceeded 90%.
FAECAL WATER ANALYSES
Faecal water was prepared by reconstituting freeze dried faeces with demineralised water to 30% dry weight, which reflects the dry weight percentage of colonic contents. l Samples were thoroughly mixed and subsequently incubated (one hour at 37°C) in a shaking water bath. After centrifugation for 20 minutes at 12 000 g (Hettich, Micro-rapid 1306, Tuttlingen, Germany), the aspirated supematant was centrifuged again for two minutes at 14000 g (Eppendorf 5415). The pH of the supernatants was measured at 37°C. Faecal waters were stored at -20°C until further use. The cytotoxic activity was determined with an erythrocyte assay as described previously" and validated elsewhere. 25 The incubations were of physiological ionic strength (154 mM) and buffered at pH 7 (final 100 mM 3-N-morpholinopropanesulphonic acid; Sigma). After acidification with HCI (final 1 M), bile acids were extracted from faecal water three times with diethyl ether. After evaporation of the diethyl ether from the pooled fractions, the residue was resolubilised in methanol. Bile acids in the methanol extracts were quantified using the same method as described for total faeces. Recoveries of a cholic acid/deoxycholic acid (Sigma) mixture, added to faecal waters, varied between 80% and 120%./ Iron was measured in faecal water diluted with distilled water as described for the diets.
STATISTICS
Results of the in vitro experiment are presented as means (SD) (n=3). Results of the infection Lactic acid (mM) 
MARKERS
All data from one animal in the LCa/LACT group were excluded from the study results The rats fed lactulose had a significantly improved colonisation resistance to S enteritidis. The first day after infection of the rats, lactulose feeding reduced faecal S enteritidis excretion about 1000-fold when compared with the low calcium control group (Fig 2, p<0 05 This adverse effect of lactulose was counteracted by supplemental calcium. In fact, faecal water of the HCa/LACT group had the lowest cytotoxic activity (Fig 4B, p<0 05) . Lactulose did not significantly affect the concentration of bile acids in faecal water, whereas calcium decreased the concentration of these surfactants ( Fig 4C, p<0 05) . Lactulose greatly increased the solubility of iron in faeces, an effect which was reversed by dietary calcium (Fig 4D, p<0O05) . The infection did not significantly affect the cytotoxicity, pH, or iron concentration of faecal water. Only in the LCa group was a significant increase in the bile acid concentration of faecal water induced by infection found (+0 59 mM).
COMPOSITION OF TOTAL FAECES
Lactulose decreased daily faecal excretion of calcium and inorganic phosphate when combined with low calcium (Table II, p<0 05) . As expected, daily faecal output of these minerals was substantially higher in the HCa/LACT group (p<005). Fermentation of lactulose by the intestinal microflora was more complete in the high calcium group. Daily lactulose excretion in faeces was 3-9 ,umol in the HCa/ LACT group, whereas the LCa/LACT group excreted more than 20 times as much (Table  II, (Fig 2) . An important product of lactulose fermentation in the rat (Table II) and human3 26 intestine is lactic acid, which seemed to be strongly bactericidal for S enteritidis (Fig 1) . Notwithstanding the improvement in colonisation resistance, lactulose did not affect translocation of S enteritidis, as measured by the kinetics of urinary NO. excretion (Fig 3) . We and are rather insensitive to the lactic acid formed, certainly when compared with the salmonella species used in this study (Fig 1) . If, in the present study, a growth advantage by lactulose supplementation was achieved for these lactic acid bacteria in the ileum, it was apparently not enough to improve the competition with and resistance to translocation of S enteitidis. By contrast with the lack of protection of lactulose against translocation of S enteitidis, the present study clearly shows that supplemental calcium phosphate is capable of diminishing translocation (Fig 3) . Thus whereas the appreciated activity of lactulose is limited to the lower gut, calcium phosphate already exerts protection in the small intestine, reducing the severity of the systemic infection. That the HCa/LACT group had the best resistance to S enteritidis infection, was supported by the absence of significant infection induced increases in faecal sodium and potassium concentrations and mucin excretion (Table I) , which are diarrhoea markers.36 37 In both low calcium groups (with or without lactulose), faecal mucin output and the concentration of faecal electrolytes increased significantly after infection. Before infection, lactulose supplementation increased the faecal electrolyte concentration, the effect being most pronounced in combination with a low calcium diet. Similar effects of lactulose on faecal sodium and potassium concentrations, in addition to softening of stools, have been reported in human studies.38 39 The lactulose fermentation mediated increased colonisation resistance to S entenitidis in this study, might also be relevant for resistance to other pathogenic bacteria. During lactulose therapy, the pH of human proximal colonic contents drops below 5V2 With the exception of shigella,40 common human pathogens such as campylobacter, Escherichia coli, and Vibrio cholerae share their acid sensitivity with S enteritidis. All these pathogens are largely killed in the acid stomach, considering that the viable oral inoculum necessary to cause intestinal disease in humans is very high (> 1 0). 14 A mechanism which might account for the improvement of the barrier function of the intestinal mucosa induced by dietary calcium is the formation of an amorphous calcium phosphate complex in the small intestine, which precipitates cytotoxic bile acids and fatty acids, thereby reducing epithelial cell damage.'2 41 In the present study, the cytotoxicity of faecal water was highest in the LCa/LACT group, intermediate in the LCa group and lowest in the HCa/LACT group (Fig 4B, p<O05) . Considering the fall in the pH of faecal water induced by lactulose fermentation (Fig 4A) , the cytotoxicity assay was performed in a buffer of neutral pH, precluding simple acid induced lysis. Excluding a direct effect on the low pH by these precautions, lactulose obviously increased the cytotoxicity of faecal water in combination with a low calcium diet. This unfavourable stimulation of the cell damaging activity of intestinal contents by lactulose fermentation was more than reversed by supplemental calcium phosphate. In accordance with its lowest cytotoxicity, faecal water of the HCa/ LACT group also has the lowest concentration of cytotoxic bile acids (Fig 4C, p<O05) . In the LCa/LACT group, the combination of a high bile acid concentration in faecal water and an enhanced protonation and absorption of these surfactants resulted in a decreased daily faecal excretion of bile acids (Table II) . When luminal calcium phosphate was limited, fermentation of lactulose greatly increased the intestinal solubility of iron (Fig 4D) . Remarkably, coprecipitation of iron by calcium phosphate" was absolutely not counteracted by the acidic colonic environment. To minimise epithelial cell damage and to maximise the barrier function of the mucosa, the solubility of iron in the intestinal lumen should be low because iron is a catalyst in Fenton-like reactions, resulting in lipid peroxidation and depletion of antioxidant defences.42 The increased luminal cytotoxicity and potential iron mediated peroxidative damage during extensive intestinal fermentation might account for the compensatory mucosal hyperproliferation in several studies. 7 9 Although most of the daily consumed dose of lactulose was metabolised by the intestinal flora, a significantly more complete fermentation was achieved on a high calcium diet when compared with the low calcium diet (Table II) . This agrees with the results of Remesy et al9 showing a more intensive fermentation of inulin on a high calcium diet. As the pH of faecal water of the HCa/LACT group was more acidic than that of the LCa/LACT group (Fig 4A, p<O005) , the increased intestinal buffering capacity, introduced by calcium phosphate, obviously facilitates fermentation until acidity finally stagnates bacterial growth. In the present study, lactulose increased faecal output of ammonia and nitrogen (Table II,  p<005 ). This agrees with results obtained in other rat43 and human studies.2 44 Besides lactulose, stimulation of faecal nitrogen output can also be achieved by consumption of other fermentable substrates such as gum arabic (human study),45 resistant starch,46 or lactitol43 (rat studies). In the present study, supplementation of the diets with calcium phosphate significantly enhanced the lactulose induced increase in faecal ammonia and nitrogen, as well as organic phosphate excretion (Table II) .
Faecal nitrogen43 47 and organic phosphate can be regarded as markers of bacterial mass. To benefit optimally from the increased fermentable substrate delivery to the lower gut, as is intended with lactulose supplementation, an adequate supply of calcium phosphate seems to be essential to stimulate the intestinal microflora. So, in addition to the intestinal acid production, the occupation of adhesion sites on the epithelium, the competition for nutrients, and the production of antimicrobials might have been increased by the extended resident flora and also have contributed to the improved resistance to S enteritidis.48 The decrease in plasma urea concentration in the lactulose supplemented groups (p<0 05) might indicate an increased rate of urea nitrogen transfer from the circulation to the intestine, as suggested by Younes et al.46 Currently the standard treatment of portosystemic encephalopathy is 100 g lactulose/ day, or roughly 160 g/kg dry food. 43 In western societies, the average dietary calcium intake is about 1 g/day, or roughly 40 mmol/kg dry food. The rat diets of the present study contained 100 g lactulose/kg dry food and 20 (low calcium) or 180 mmol calcium/kg dry food (high calcium). Although a direct extrapolation of the results from the present rat study to the human situation is inappropriate, the relatively high dose of lactulose prescribed to humans and their relatively low dietary calcium intake warrants serious concern about the balance between these food ingredients in humans.
In conclusion, the present study shows 
